Pular para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Título
Autor
Assunto
Número de Chamada
ISBN/ISSN
Tag
Buscar
Avançada
Topotecan in mantle cell lymph...
Citar
Enviar por SMS
Enviar por e-mail
Imprimir
Exportar registro
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Link permanente
Topotecan in mantle cell lymphoma - A 21 day continuous infusion regimen may have advantages over intermittent therapy.
Detalhes bibliográficos
Principais autores:
Poynton, C
,
Maughan, T
,
Hasan, F
,
Falk, S
,
Shelley, M
,
Smith, P
Formato:
Journal article
Publicado em:
2001
Itens
Descrição
Registros relacionados
Registro fonte
Registros relacionados
Clinical impact of diagnostic discrepancies identified by central pathological review of lymphomas - A report of the All Wales Lymphoma Pathology Group
por: Dojcinov, S, et al.
Publicado em: (2001)
Mantle Cell Lymphoma Masquerading as obstructive sleep apnoea
por: Ishak, Noor Liza, et al.
Publicado em: (2022)
Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya
por: Mugo, PM, et al.
Publicado em: (2014)
A novel calcium infusion regimen after parathyroidectomy for renal hyperparathyroidism
por: Tan, Jih Huei, et al.
Publicado em: (2017)
The clinical impact of expert pathological review on lymphoma management: a regional experience.
por: Lester, J, et al.
Publicado em: (2003)